Nicholas Moore

19.5k total citations · 1 hit paper
411 papers, 13.3k citations indexed

About

Nicholas Moore is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Toxicology. According to data from OpenAlex, Nicholas Moore has authored 411 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pharmacology, 69 papers in Cardiology and Cardiovascular Medicine and 63 papers in Toxicology. Recurrent topics in Nicholas Moore's work include Pharmacovigilance and Adverse Drug Reactions (59 papers), Inflammatory mediators and NSAID effects (37 papers) and Pharmaceutical Practices and Patient Outcomes (28 papers). Nicholas Moore is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (59 papers), Inflammatory mediators and NSAID effects (37 papers) and Pharmaceutical Practices and Patient Outcomes (28 papers). Nicholas Moore collaborates with scholars based in France, Belize and China. Nicholas Moore's co-authors include Alexandre Pariente, Mathiéu Molimard, Pierre Philip, Patricia Sagaspe, Annie Fourrier‐Réglat, Bernard Bégaud, R. Lassalle, Patrick Blin, Jacques Taillard and Bernard Bioulac and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Nicholas Moore

397 papers receiving 12.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

2017 398 citations R. Lassalle, Alexandre Pariente et al. Pharmacoepidemiology and Drug Safety profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas Moore France	60	2.1k	1.9k	1.7k	1.4k	1.4k	411	13.3k
Toine C. G. Egberts Netherlands	72	2.0k 1.0×	474 0.3×	2.7k 1.6×	1.1k 0.8×	768 0.6×	512	18.2k
Wayne A. Ray United States	75	3.9k 1.9×	734 0.4×	584 0.3×	1.1k 0.8×	1.1k 0.8×	215	21.5k
Alan D. Kaye United States	61	3.6k 1.7×	325 0.2×	359 0.2×	1.8k 1.3×	2.3k 1.7×	1.1k	19.5k
Ian Chi Kei Wong United Kingdom	61	973 0.5×	257 0.1×	750 0.4×	1.1k 0.8×	932 0.7×	668	16.8k
Thomas J. Moore United States	47	1.5k 0.7×	525 0.3×	278 0.2×	1.2k 0.9×	3.8k 2.7×	162	17.1k
Miriam Sturkenboom Netherlands	68	3.0k 1.5×	126 0.1×	1.5k 0.9×	1.4k 1.0×	2.3k 1.7×	461	18.0k
Bruno H. Stricker Netherlands	90	2.1k 1.0×	343 0.2×	603 0.4×	3.7k 2.6×	3.7k 2.7×	571	30.4k
Liesi E. Hebert United States	43	2.0k 1.0×	383 0.2×	188 0.1×	1.2k 0.9×	3.2k 2.3×	59	15.1k
R Andrew Moore United Kingdom	54	3.5k 1.7×	282 0.2×	186 0.1×	1.1k 0.8×	3.4k 2.5×	133	21.7k
Adam F. Cohen Netherlands	46	805 0.4×	301 0.2×	288 0.2×	1.4k 1.0×	943 0.7×	288	7.7k

Countries citing papers authored by Nicholas Moore

Since Specialization

Citations

This map shows the geographic impact of Nicholas Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Moore more than expected).

Fields of papers citing papers by Nicholas Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Moore. The network helps show where Nicholas Moore may publish in the future.

Co-authorship network of co-authors of Nicholas Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Moore. A scholar is included among the top collaborators of Nicholas Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Moore. Nicholas Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blin, Patrick, Michaël Joubert, Patrick Jourdain, et al.. (2024). Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database. Cardiovascular Diabetology. 23(1). 22–22. 3 indexed citations

Daoud, F., Louis Létinier, Nicholas Moore, Pierre Coste, & Pasi P. Karjalainen. (2022). Efficacy and Safety of TiNO-Coated Stents versus Drug-Eluting Stents in Acute Coronary Syndrome: Systematic Literature Review and Meta-Analysis. Biomedicines. 10(12). 3159–3159. 3 indexed citations

Russell, C., Andrew C. Dixson, Daiane S. Alves, et al.. (2022). The Candida albicans virulence factor candidalysin polymerizes in solution to form membrane pores and damage epithelial cells. eLife. 11. 26 indexed citations

Thurin, Nicolas H., Jérémy Jové, Xavier Rébillard, et al.. (2020). Changes in therapeutic strategy in metastatic castration resistant prostate cancer (mCRPC) between 2012 and 2014 from the French nationwide claims database (SNDS). European Urology Open Science. 19. e901–e901. 1 indexed citations

Moore, Nicholas, et al.. (2017). Public Knowledge and Attitude towards Antibiotic Use in Lebanon. 5(2). 35–41. 5 indexed citations

Moore, Nicholas, et al.. (2017). Community Usage Pattern of Antibiotics within Lebanese Population: A Prospective Study. 5(2). 49–56. 1 indexed citations

Dureau‐Pournin, C., Jean‐Michel Pedespan, C. Droz‐Perroteau, et al.. (2013). Continuation rates of levetiracetam in children from the EULEVp cohort study. European Journal of Paediatric Neurology. 18(1). 19–24. 4 indexed citations

Guelfucci, Florent, E. Clay, Samuel Aballéa, et al.. (2013). Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France. BMC Endocrine Disorders. 13(1). 15–15. 7 indexed citations

Orriols, Ludivine, Pierre Philip, Blandine Gadegbeku, et al.. (2012). Risk of Injurious Road Traffic Crash After Prescription of Antidepressants. The Journal of Clinical Psychiatry. 73(8). 1088–1094. 30 indexed citations

10.

Pariente, Alexandre, Paul Avillach, Francesco Salvo, et al.. (2012). Effect of Competition Bias in Safety Signal Generation. Drug Safety. 35(10). 855–864. 59 indexed citations

11.

Upur, Halmurat, et al.. (2012). The impact of the Uighur medicine abnormal savda munziq on antitumor and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumor model. Pharmacognosy Magazine. 8(30). 141–141. 13 indexed citations

12.

Daveluy, Amélie, Ghada Miremont‐Salamé, Catherine Lecomte, et al.. (2012). Identification of abuse and dependence cases through a hospital database. Pharmacoepidemiology and Drug Safety. 21(12). 1344–1349. 21 indexed citations

13.

Devriès, C, Miriam Sturkenboom, Susana Perez‐Gutthann, et al.. (2011). SALT-I (Study of Acute Liver Transplant) : étude de l’insuffisance hépatique aiguë liée aux AINS dans des centres de transplantation hépatique européens. Revue d Épidémiologie et de Santé Publique. 59. S73–S74. 1 indexed citations

14.

Fourrier‐Réglat, Annie, C. Droz‐Perroteau, Jacques Bénichou, et al.. (2008). Impact of Prescriber Nonresponse on Patient Representativeness. Epidemiology. 19(2). 186–190. 19 indexed citations

15.

Mittleman, Murray A., Malcolm Maclure, Michael A. O. Lewis, et al.. (2008). Cardiovascular outcomes among sildenafil users: results of the International Men’s Health Study. International Journal of Clinical Practice. 62(3). 367–373. 10 indexed citations

16.

Upur, Halmurat, et al.. (2007). [Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells].. PubMed. 32(11). 1068–71. 6 indexed citations

17.

Picard, Stéphane, Karine Titier, Gabriel Étienne, et al.. (2006). Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood. 109(8). 3496–3499. 468 indexed citations

18.

Taillard, Jacques, Nicholas Moore, Bruno Claustrat, et al.. (2006). Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humans. Journal of Sleep Research. 15(1). 41–45. 13 indexed citations

19.

Moore, Nicholas, Hélène Verdoux, & Bruno Fantino. (2005). Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. International Clinical Psychopharmacology. 20(3). 131–137. 152 indexed citations

20.

Moore, Nicholas, et al.. (1994). Endothelins. Drugs & Aging. 4(3). 221–237. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact